Related Experiment Video
Updated: Aug 13, 2025
08:46
Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
Published on: January 26, 2024
1.8K
Metagenome data-based phage therapy for intestinal bacteria-mediated diseases
1Department of Immunology and Genomics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka-shi, Osaka 545-8585, Japan.
Bioscience of Microbiota, Food and Health
|January 20, 2023
Summary
Next-generation phage therapy offers a targeted approach to control harmful gut bacteria without harming beneficial microbes. This review highlights its potential, especially for conditions like Clostridioides difficile infection.
Area of Science:
- Microbiology
- Genomics
- Virology
Background:
- Intestinal microbiota dysbiosis is linked to various diseases.
- Commensal pathogens contribute to disease onset and severity.
- Antibiotics are unsuitable for controlling gut pathogens due to broad-spectrum effects.
Purpose of the Study:
- To review the significance of next-generation phage therapy.
- To explore phage therapy's potential for controlling intestinal commensal pathogens.
- To present a novel therapy for Clostridioides difficile using metagenomic data.
Main Methods:
- Utilizing next-generation sequencing for genome analysis.
- Leveraging metagenomic data for phage discovery and characterization.
- Developing targeted phage-based interventions.
Main Results:
- Phages exhibit high specificity for targeting bacteria.
- Metagenomic approaches overcome limitations in culturing anaerobic intestinal bacteria.
- A novel phage therapy for Clostridioides difficile has been developed.
Conclusions:
- Phage therapy is a promising alternative for controlling specific gut pathogens.
- Metagenomics is crucial for advancing phage therapy in complex environments like the gut.
- Next-generation phage therapy holds potential for treating gut-related diseases.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
116
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
116
01:30Lytic Cycle of Bacteriophages
71.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.4K
01:26DNA Bacteriophages
85
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
85
00:43Lysogenic Cycle of Bacteriophages
62.8K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.8K
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
500
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
500
01:16Viral Replication: Lysogenic Cycle
113
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
113